Microalbuminuria: a parameter that has changed diabetes care.

Area of Science:

• Nephrology
• Cardiology
• Diabetology

Background:

• Diabetic nephropathy involves persistent albuminuria, hypertension, declining GFR, and increased cardiovascular disease (CVD) risk.
• Microalbuminuria is crucial for managing diabetic nephropathy and CVD in diabetic patients.
• Remission of microalbuminuria is observed in both type 1 and type 2 diabetes, highlighting the significance of urinary albumin excretion.

Purpose of the Study:

• To emphasize the importance of microalbuminuria as a screening tool for diabetic nephropathy.
• To highlight the role of microalbuminuria remission in preserving renal function.
• To underscore microalbuminuria's predictive power for cardiovascular outcomes in diabetes.

Main Methods:

• Review of clinical practice guidelines and research on diabetic nephropathy and cardiovascular disease.
• Evaluation of microalbuminuria as a biomarker compared to novel biomarkers.
• Analysis of factors influencing the development and remission of albuminuria.

Main Results:

• Microalbuminuria remains the most effective screening tool for diabetic nephropathy.
• Remission of microalbuminuria is associated with preserved renal function.
• Microalbuminuria is a strong independent predictor of fatal and nonfatal cardiovascular events in diabetes.

Conclusions:

• Sustained microalbuminuria indicates a higher risk for kidney function decline and cardiovascular events.
• Interventions like improved glycemic control, blood pressure reduction, and RAS blockade are vital.
• Multifactorial risk factor management reduces the incidence of albuminuria and cardiovascular events in diabetic patients.